Research
Evidence reviews of the drugs sold online — semaglutide, tirzepatide, and what the trials behind them actually measured. No secondary summaries: every claim traced to the trial, the label, or the paper of record.
6 articles
- Formats
Compounded GLP-1: what the label does not have to tell you
The low figures on this desk are compounded preparations, and a compounded product is a different regulatory route rather than a discount on the same drug.
8 min read - Safety
GLP-1, contraception and sexual function: four questions, one answered
Contraceptive drug exposure has been measured once and narrowly; male testosterone has a small meta-analysis; erectile function is contested; female libido is unstudied.
8 min read - Evidence
GLP-1 for PCOS and after menopause: what has actually been measured
Both are high-intent questions with thinner direct evidence than the volume of writing suggests, and the gap is worth naming precisely.
8 min read - Evidence
Who pays for a GLP-1, and what happens when nobody does
Coverage decides the bill before any seller quotes a price, and the published data on copays and discontinuation says what happens next.
7 min read - Evidence
Most people stop inside six months, and the prepay rate assumes they do not
Real-world cohorts put six-month discontinuation between a third and a half, which is the missing half of every twelve-month price on this desk.
7 min read - Formats
Buying a GLP-1 through a telehealth seller: the three gates before the price
Eligibility, state licensure and supply each sit above the figure on a pricing page, and each is controlled by someone different.
7 min read